Basic Concepts and Methods for Joint Models of Longitudinal and Survival Data

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2010 May 5

PMID 20439643

Citations 174

Authors

Joseph G Ibrahim

Haitao Chu

Liddy M Chen

Affiliations

Soon will be listed here.

Abstract

Joint models for longitudinal and survival data are particularly relevant to many cancer clinical trials and observational studies in which longitudinal biomarkers (eg, circulating tumor cells, immune response to a vaccine, and quality-of-life measurements) may be highly associated with time to event, such as relapse-free survival or overall survival. In this article, we give an introductory overview on joint modeling and present a general discussion of a broad range of issues that arise in the design and analysis of clinical trials using joint models. To demonstrate our points throughout, we present an analysis from the Eastern Cooperative Oncology Group trial E1193, as well as examine some operating characteristics of joint models through simulation studies.

Citing Articles

Evaluation of factors related to longitudinal CD4 count and the risk of death among HIV-infected patients using Bayesian joint models.

Pilangorgi S, Khodakarim S, Shayan Z, Nejat M BMC Public Health. 2025; 25(1):979.

PMID: 40075339 PMC: 11905675. DOI: 10.1186/s12889-025-22096-6.

Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies.

Baneshi M, Mishra G, Dobson A BMJ Public Health. 2025; 2(2):e000963.

PMID: 40018552 PMC: 11816716. DOI: 10.1136/bmjph-2024-000963.

Analysis of Cohort Stepped Wedge Cluster-Randomized Trials With Nonignorable Dropout via Joint Modeling.

Gasparini A, Crowther M, Hoogendijk E, Li F, Harhay M Stat Med. 2025; 44(5):e10347.

PMID: 39963907 PMC: 11833761. DOI: 10.1002/sim.10347.

Joint modelling of longitudinal data: a scoping review of methodology and applications for non-time to event data.

Ouko R, Mukaka M, Ohuma E BMC Med Res Methodol. 2025; 25(1):40.

PMID: 39962370 PMC: 11831847. DOI: 10.1186/s12874-025-02485-6.

The Dynamics of Cognitive Decline towards Alzheimer's Disease Progression: Results from ADSP-PHC's Harmonized Cognitive Composites.

Kang K, Zhang P, Dumitrescu L, Mukherjee S, Lee M, Choi S medRxiv. 2025; .

PMID: 39830238 PMC: 11741457. DOI: 10.1101/2025.01.01.25319850.

References

Faucett C, Thomas D . Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Stat Med. 1996; 15(15):1663-85. DOI: 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1. View

Kirkwood J, Ibrahim J, Sosman J, Sondak V, Agarwala S, Ernstoff M . High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol. 2001; 19(9):2370-80. DOI: 10.1200/JCO.2001.19.9.2370. View

Law N, Taylor J, Sandler H . The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics. 2003; 3(4):547-63. DOI: 10.1093/biostatistics/3.4.547. View

de Gruttola V, Tu X . Modelling progression of CD4-lymphocyte count and its relationship to survival time. Biometrics. 1994; 50(4):1003-14. View

Hsieh F, Tseng Y, Wang J . Joint modeling of survival and longitudinal data: likelihood approach revisited. Biometrics. 2006; 62(4):1037-43. DOI: 10.1111/j.1541-0420.2006.00570.x. View

Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S . Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997; 15(3):974-86. DOI: 10.1200/JCO.1997.15.3.974. View

Faucett C, Schenker N, Taylor J . Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data. Biometrics. 2002; 58(1):37-47. DOI: 10.1111/j.0006-341x.2002.00037.x. View

Henderson R, Diggle P, Dobson A . Joint modelling of longitudinal measurements and event time data. Biostatistics. 2003; 1(4):465-80. DOI: 10.1093/biostatistics/1.4.465. View

Chi Y, Ibrahim J . Joint models for multivariate longitudinal and multivariate survival data. Biometrics. 2006; 62(2):432-45. DOI: 10.1111/j.1541-0420.2005.00448.x. View

10.

Xu J, Zeger S . The evaluation of multiple surrogate endpoints. Biometrics. 2001; 57(1):81-7. DOI: 10.1111/j.0006-341x.2001.00081.x. View

11.

Kirkwood J, Ibrahim J, Sondak V, Richards J, Flaherty L, Ernstoff M . High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol. 2000; 18(12):2444-58. DOI: 10.1200/JCO.2000.18.12.2444. View

12.

Brown E, Ibrahim J, DeGruttola V . A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics. 2005; 61(1):64-73. DOI: 10.1111/j.0006-341X.2005.030929.x. View

13.

Brown E, Ibrahim J . A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. Biometrics. 2003; 59(2):221-8. DOI: 10.1111/1541-0420.00028. View

14.

LaValley M, Degruttola V . Models for empirical Bayes estimators of longitudinal CD4 counts. Stat Med. 1996; 15(21-22):2289-305; discussion 2337-40. DOI: 10.1002/(SICI)1097-0258(19961115)15:21<2289::AID-SIM449>3.0.CO;2-I. View

15.

Song X, Davidian M, Tsiatis A . An estimator for the proportional hazards model with multiple longitudinal covariates measured with error. Biostatistics. 2003; 3(4):511-28. DOI: 10.1093/biostatistics/3.4.511. View

16.

Hogan J, Laird N . Model-based approaches to analysing incomplete longitudinal and failure time data. Stat Med. 1997; 16(1-3):259-72. DOI: 10.1002/(sici)1097-0258(19970215)16:3<259::aid-sim484>3.0.co;2-s. View

17.

Wulfsohn M, Tsiatis A . A joint model for survival and longitudinal data measured with error. Biometrics. 1997; 53(1):330-9. View

18.

Brown E, Ibrahim J . Bayesian approaches to joint cure-rate and longitudinal models with applications to cancer vaccine trials. Biometrics. 2003; 59(3):686-93. DOI: 10.1111/1541-0420.00079. View

19.

Schluchter M . Methods for the analysis of informatively censored longitudinal data. Stat Med. 1992; 11(14-15):1861-70. DOI: 10.1002/sim.4780111408. View